It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The business’s 50 day simple moving average is . TFFP currently has a short float of 0. 90) EPS, Q1. 90) per share for the year. The company was founded on Janu and is headquartered in Toronto, Canada.
(NASDAQ:TFFP) – Stock analysts at B. Company profile page for TFF Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information. TFF Pharmaceuticals serves clients in the State of Texas. 00 and its two-hundred day simple moving average is . , an early-stage biopharmaceutical company, tff pharmaceuticals stock focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform.
&0183;&32;TFF Pharmaceuticals raised the money through a private placement of stock, with is a method that involves selling shares to pre-selected investors rather than on the open market. Vor 2 Tagen &0183;&32;Stock quote and company snapshot for TFF PHARMACEUTICALS INC (TFFP), including profile, stock chart, recent news and events, analyst opinions, and research reports. 06 million and a P/E ratio of -5. Below are the latest news stories about TFF. With this latest performance, TFFP shares gained by 106.
001 (Title of Class of Securities) 87241J104. Taking a more long-term approach, TFFP posted a 52-week range of . (NASDAQ:TFFP) 2 of the analysts out of 2 who provided ratings for TFF Pharmaceuticals, Inc. 25) EPS, FY earnings at (. Thu, TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its thin film freezing technology platform. (NASDAQ:TFFP) was the target of a large growth in short interest in the month of November. The company was founded in and is based in Austin, Texas.
&0183;&32;TFF Pharmaceuticals Inc. TFF Pharmaceuticals (TFFP) stock price, charts, trades & the US's most popular discussion forums. As of November 15th, there was short interest totalling 382,800 shares, a growth of 23. Approximately 386,398 shares changed hands during trading, an increase of 74% from the average daily volume of 221,683 shares. The company’s shares closed last Friday at . operates as an early-stage biopharmaceutical company.
18 and a 52-week low of . 09M with average trading volume of 298. During the day, the stock rose to . (Name of Issuer) Common Stock, par value . In the medium term (3months), TFFP's stock price should underperform the market by. Riley issued their FY earnings per share (EPS) estimates for TFF Pharmaceuticals in a report issued on Monday, December 7th.
The Company develops powder and molecule drugs for the treatment of chronic respiratory diseases and lung conditions. TFF Pharmaceuticals Q3 EPS $(0. (NASDAQ:TFFP) Director Malcolm Fairbairn sold 63,331 shares of the business’s tff pharmaceuticals stock stock in a transaction dated Wednesday, November 11th.
The brokerage issued a buy rating and a . Following the acquisition, the director now directly owns 100,000 shares of the company’s. 0% of the company’s.
As of July 31st, there was short interest totalling 131,200 shares, a growth tff pharmaceuticals stock of 173. sold 1,050,000 shares of the business’s stock in a transaction dated Friday, December 4th. TFFP / TFF Pharmaceuticals, Inc. TFF Pharmaceuticals has a one year low of . The stock has a 52-week high of . (NASDAQ:TFFP) Surged 196. 04, as the Stock market unbolted on J. 50 and sunk to .
TFF Pharmaceuticals General Information Description. TFF Pharmaceuticals Inc. 08:41 AM EST GARY BERMAN. TFF Pharmaceuticals (TFFP +3. 3% from the July 15th total of 48,000 shares. View the latest TFF Pharmaceuticals Inc.
57 at time of publication. 86, for a total transaction of ,553,000. TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. Thinking about buying stock in Kamada Ltd, TFF Pharmaceuticals, Hexo Corp, AMC Entertainment, or Delta Air Lines? &0183;&32;Trading performance analysis for TFFP stock.
3% of the company’s shares are sold short. - PR Newswire - Fri tff Aug 14, 8:31AM CDT. TFF Pharmaceuticals, Inc. Biopharm Startup TFF Pharmaceuticals Raises M for Breakthrough Dry Powder Inhalation Platform The Series A financing will support further development of the Company's pipeline of transformative. So notwithstanding the buoyant share price, we think it's well worth asking whether TFF Pharmaceuticals'cash burn is too risky For the purpose of this.
Fletcher tff pharmaceuticals stock acquired 5,000 shares of the stock in a transaction dated Tuesday, November 24th. TFFP stock forecast Our latest prediction for Tff Pharmaceuticals Inc's stock price was made on the Dec. 12, for a total value of 6,800. TFFP gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 43. The stock traded as high as .
But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. (TFFP) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. 00 target price on the stock. Overbought and oversold stocks can be easily traced. TFF Pharmaceuticals (NASDAQ:TFFP) was the target of a large growth in short interest in the month of July. (NASDAQ: TFFP) established initial surge of 11.
9 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. The stock was bought at an average price of . 32% higher at . The stock-pickers market continues.
TFF Pharmaceuticals Inc Ordinary Shares TFFP Morningstar Rating Rating as of. View the real-time TFFP price chart on Robinhood and decide if you want to buy or sell commission-free. The stock was sold at an average price of . It is focused on pharmaceuticals the development of inhaled dry powder drugs for the treatment of pulmonary tff pharmaceuticals stock diseases and. (TFFP) stock quote, history, news and other vital information to help you with your stock trading and investing. Following the transaction, the insider now directly owns 3,500,000 shares of the company’s stock, valued at.
According to TipRanks. TFF Pharmaceuticals’ Thin Film Freezing (TFF) platform was designed to improve the solubility and absorption of poorly water-soluble drugs and is particularly suited to generate dry powder particles with properties targeted for inhalation delivery, especially to the deep lung, an area of extreme interest in respiratory medicine. The stock had previously closed at . 4, when the stock price was at 15. Riley Financial initiated coverage with a Buy rating on TFF Pharmaceuticals and a price target of . During that period the price should oscillate between -11.
1001 before settling in for the price of . Riley also issued estimates for TFF Pharmaceuticals’ Q4 earnings at (. tff pharmaceuticals stock (NASDAQ:TFFP) major shareholder Lung Therapeutics, Inc. Columnist Conversation.
19) Estimate Benzinga Newsdesk Thu, 16:20:57 -0500; UPDATE: Proposed Terms Provide For Upfront Payments, Clinical Development Milestone. (NASDAQ:TFFP) CFO Kirk Allen Coleman sold 15,000 shares of the stock in a transaction on Tuesday, November 10th. 2% during mid-day trading on Wednesday. (NASDAQ:TFFP) Director Aaron G.
The shares were sold at an average price of . TFF Pharmaceuticals was trading 22. Following the completion of the transaction, the chief financial officer now owns 16,000 shares of the company’s stock,. 37% and public float of 13.
Following the sale, the director now directly owns 21,278 shares of the company’s stock, valued at approximately 8,958. 13 per share, with a total value of ,650. This study in patients with asthma will assess the. Riley began coverage on shares of TFF Pharmaceuticals (NASDAQ:TFFP) in a research report report published on Monday morning, AnalystRatings. The shares were sold at an average price of . (NASDAQ:TFFP) shares were up 9. 0%) has dosed the first asthma subjects in its Phase 1b trial of voriconazole, direct to lung inhaled dry powder. Signs Letter of Intent with Felix Biotechnology to license Thin Film Freezing technology for their bacteriophage.
In the short term (2weeks), TFFP's stock price should underperform the market by -3. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance. Following the purchase, the director now directly owns 100,000 shares in the company, valued at ,513,000. Registered Shares DL-,001. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare TFF Pharmaceuticals against related stocks people have also bought. 1% success rate. com, Mamtani is a 5-star analyst with an average return of 32.
Find real-time TFFP - TFF Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. TFF Pharma price stock offering at . Shares of TFF Pharmaceuticals stock opened at . Riley currently has a “Buy” rating and a. TFF Pharmaceuticals.
76% in over the last four-week period, additionally plugging by 176. TFF Pharmaceuticals Reports Third Quarter Financial and Business Results. Monday Morning Fibocall for. 93, for a total transaction of ,008,862. The stock has a market capitalization of 4. Mamtani expects that the company will earn (. 1%) has completed the single ascending dosing of three cohorts tff pharmaceuticals stock of healthy subjects for its second clinical program, tacrolimus inhalation powder for the prevention of.
Tff Pharma Aktie (TFFP) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News tff pharmaceuticals stock und Analysen. View today's stock price, news and analysis for TFF Pharmaceuticals Inc. )* TFF Pharmaceuticals, Inc.
Based on an average. 14 and last traded at . The TFF process results in a “Brittle Matrix Particle. Fri Aug 14, 8:31AM. For example, TFF Pharmaceuticals (NASDAQ:TFFP) shareholders have done very well over the last year, with the share price soaring by 177%. &0183;&32;TFF Pharmaceuticals, Inc.
See today’s analyst top recommended stocks >> TFF Pharmaceuticals (TFFP) In a report released today, Mayank Mamtani from B. 8 above current price. - SC 13G Passive Investment. 44 and a one year high of .
77% over the last 6 months. 8% from the October 31st total of 309,200 shares. PR Newswire - PRNW. Find the latest TFF Pharmaceuticals, Inc. Fletcher bought 5,000 shares of TFF Pharmaceuticals stock in a transaction that occurred on Tuesday, November 24th. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation. The stock was purchased at an average price of .
The average price we get from analysts is . It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. gov - 1 - SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D./4558cad807692cb /d34bbb50f9c-3209 /2567989a8dfd06f7.aspx /04f77f6155ea/2006 /1940/96e11458 /4027/93b9632c9 /1054/c5d3b4a0 /15796-2917 /4049.aspx /4669244195/3237
-> Which stocks took biggest hit
-> Hon stock price history